Randomized Comparison of Minimally Invasive Direct Coronary Artery Bypass Surgery Versus Sirolimus-Eluting Stenting in Isolated Proximal Left Anterior Descending Coronary Artery Stenosis

Journal of the American College of Cardiology

Volumn 53, Issue 25, 2009, Pages 2324-2331

  Thiele, Holger ^a   Neumann Schniedewind, Patrick ^a   Jacobs, Stephan ^a   Boudriot, Enno ^a   Walther, Thomas ^a   Mohr, Friedrich Wilhelm ^a   Schuler, Gerhard ^a   Falk, Volkmar ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

atherosclerosis; bypass; coronary artery disease; drug eluting stents; restenosis

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HEPARIN; INOTROPIC AGENT; RAPAMYCIN;

ADULT; AGED; ANGINA PECTORIS; ANGIOCARDIOGRAPHY; AORTA THROMBOSIS; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS SURGERY; CORONARY ARTERY OBSTRUCTION; DRUG ELUTING STENT; FALSE ANEURYSM; FEMALE; FOLLOW UP; FORWARD HEART FAILURE; GENERAL CONDITION IMPROVEMENT; HEART DEATH; HEART INFARCTION; HEMATOMA; HEPARIN INDUCED THROMBOCYTOPENIA; HUMAN; INVASIVE PROCEDURE; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE COMPLICATION; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REOPERATION; RESTENOSIS; REVASCULARIZATION;

AGED; CORONARY ANGIOGRAPHY; CORONARY ARTERY BYPASS; CORONARY STENOSIS; DRUG-ELUTING STENTS; EXERCISE TOLERANCE; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSTHESIS IMPLANTATION; QUALITY OF LIFE; SIROLIMUS; SURGICAL PROCEDURES, MINIMALLY INVASIVE; TREATMENT OUTCOME;

EID: 66949140697     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2009.03.032     Document Type: Article

References (30)

1. Varnauskas E. Twelve-year follow-up of survival in the randomized European Coronary Surgery Study. N Engl J Med 319 (1988) 332-337
2. Klein L.W., Weintraub W.S., Agarwal J.B., et al. Prognostic significance of severe narrowing of the proximal portion of the left anterior descending coronary artery. Am J Cardiol 58 (1986) 42-46
3. Diegeler A., Thiele H., Falk V., et al. Comparison of stenting with minimally invasive bypass surgery for stenosis of the left anterior descending coronary artery. N Engl J Med 347 (2002) 561-566
4. Jaffery Z., Kowalski M., Weaver W.D., and Khanal S. A meta-analysis of randomized control trials comparing minimally invasive direct coronary bypass grafting versus percutaneous coronary intervention for stenosis of the proximal left anterior descending artery. Eur J Cardiothorac Surg 31 (2007) 691-697
5. Thiele H., Oettel S., Jacobs S., et al. Comparison of bare-metal stenting with minimally invasive bypass surgery for stenosis of the left anterior descending coronary artery. A 5 year follow-up. Circulation 112 (2005) 3445-3450
6. Morice M.C., Serruys P.W., Sousa J.E., et al. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 346 (2002) 1773-1780
7. Moses J.W., Leon M.B., Popma J.J., et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 349 (2003) 1315-1323
8. Hong S.J., Lim D.S., Seo H.S., et al. Percutaneous coronary intervention with drug-eluting stent implantation vs. minimally invasive direct coronary artery bypass (MIDCAB) in patients with left anterior descending coronary artery stenosis. Catheter Cardiovasc Interv 64 (2005) 75-81
9. Khattab A.A., Hamm C.W., Senges J., et al. Sirolimus-eluting stent treatment for isolated proximal left anterior descending artery stenoses. Z Kardiol 94 (2005) 187-192
10. Sawhney N., Moses J.W., Leon M.B., et al. Treatment of left anterior descending coronary artery disease with sirolimus-eluting stents. Circulation 110 (2004) 374-379
11. Dangas G., Ellis S.G., Shlofmitz R., et al. Outcomes of paclitaxel-eluting stent implantation in patients with stenosis of the left anterior descending coronary artery. J Am Coll Cardiol 45 (2005) 1186-1192
12. Diegeler A., Falk V., Matin M., et al. Minimally invasive coronary artery bypass grafting without cardiopulmonary bypass: early experience and follow-up. Ann Thorac Surg 66 (1998) 1022-1025
13. Valenti L., Lim L., Heller R.F., and Knapp J. An improved questionnaire for assessing quality of life after acute myocardial infarction. Qual Life Res 5 (1996) 151-161
14. Ware J.E., Kosinski M., and Gandek B. SF-36 Health Survey: Manual & Interpretation Guide (2000), Qualimetric Inc., Lincoln, Rhode Island
15. Thygesen K., Alpert J.S., and White H.D. Universal definition of myocardial infarction. Circulation 116 (2007) 2634-2653
16. Cutlip D.E., Windecker S., Mehran R., et al. Clinical end points in coronary stent trials. Circulation 115 (2007) 2344-2351
17. Blackwelder W.C. "Proving the null hypothesis" in clinical trials. Control Clin Trials 3 (1982) 345-353
18. Chan I.S. Exact tests of equivalence and efficacy with a non-zero lower bound for comparative studies. Stat Med 17 (1998) 1403-1413
19. Ryan T.J., Faxon D.P., Gunnar G.M., et al. Guidelines for percutaneous transluminal coronary angioplasty: a report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Subcommittee on Percutaneous Transluminal Coronary Angioplasty). Circulation 78 (1988) 486-502
20. Kastrati A., Schomig A., Elezi S., et al. Predictive factors of restenosis after coronary stent placement. J Am Coll Cardiol 30 (1997) 1428-1436
21. Schomig A., Dibra A., Windecker S., et al. A meta-analysis of 16 randomized trials of sirolimus-eluting stents versus paclitaxel-eluting stents in patients with coronary artery disease. J Am Coll Cardiol 50 (2007) 1373-1380
22. Windecker S., Remondino A., Eberli F.R., et al. Sirolimus-eluting and paclitaxel-eluting stents for coronary revascularization. N Engl J Med 353 (2005) 653-662
23. Morice M.C., Colombo A., Meier B., et al. Sirolimus- vs paclitaxel-eluting stents in de novo coronary artery lesions. The REALITY trial: a randomized controlled trial. JAMA 295 (2006) 895-904
24. Ben-Gal Y., Mohr R., Braunstein R., et al. Revascularization of left anterior descending artery with drug-eluting stents: comparison with minimally invasive direct coronary artery bypass surgery. Ann Thorac Surg 82 (2006) 2067-2071
25. Cutlip D.E., Baim D.S., Ho K.K., et al. Stent thrombosis in the modern era: a pooled analysis of multicenter coronary stent clinical trials. Circulation 103 (2001) 1967-1971
26. Grines C.L., Bonow R.O., Casey D.E.J., et al. Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents. J Am Coll Cardiol 49 (2007) 734-739
27. Wiviott S.D., Braunwald E., McCabe C.H., et al. Intensive oral antiplatelet therapy for reduction of ischaemic events including stent thrombosis in patients with acute coronary syndromes treated with percutaneous coronary intervention and stenting in the TRITON-TIMI 38 trial: a subanalysis of a randomised trial. Lancet 371 (2008) 1353-1363
28. Drenth D.J., Winter J.B., Veeger N.J., et al. Minimally invasive coronary artery bypass grafting versus percutaneous transluminal coronary angioplasty with stenting in isolated high-grade stenosis of the proximal left anterior descending coronary artery: Six months' angiographic and clinical follow-up of a prospective randomized study. J Thorac Cardiovasc Surg 124 (2002) 130-135
29. Cameron A., Davis K.B., Green G., and Schaff H.V. Coronary bypass surgery with internal-thoracic-artery grafts-effects on survival over a 15-year period. N Engl J Med 334 (1996) 216-219
30. Holzhey D.M., Jacobs S., Mochalski M., et al. Seven-year follow-up after minimally invasive direct coronary artery bypass: experience with more than 1300 patients. Ann Thorac Surg 83 (2007) 108-114